Publicaciones en colaboración con investigadores/as de Hospital Sant Joan de Deu (12)

2024

  1. Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo

    Science translational medicine, Vol. 16, Núm. 734, pp. eadg7962

2023

  1. Crisis neonatales y evolución a epilepsia en un hospital de tercer nivel

    Revista de neurologia, Vol. 77, Núm. 10, pp. 249-252

2022

  1. CD34+CD19−CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies

    Blood, Vol. 140, Núm. 1, pp. 38-44

  2. Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia

    Molecular Oncology, Vol. 16, Núm. 16, pp. 2899-2919

2019

  1. Pattern-sensitive neurons reveal encoding of complex auditory regularities in the rat inferior colliculus

    NeuroImage, Vol. 184, pp. 889-900

2018

  1. Cognitive reserve as an outcome predictor: first-episode affective versus non-affective psychosis

    Acta Psychiatrica Scandinavica, Vol. 138, Núm. 5, pp. 441-455

  2. Complex multiple risk intervention to promote healthy behaviours in people between 45 to 75 years attended in primary health care (EIRA study): Study protocol for a hybrid trial

    BMC Public Health, Vol. 18, Núm. 1

2017

  1. Neurons along the auditory pathway exhibit a hierarchical organization of prediction error

    Nature Communications, Vol. 8, Núm. 1

2015

  1. Manejo de la sedación y la analgesia en unidades de cuidados intensivos neonatales españolas

    Anales de Pediatria, Vol. 83, Núm. 2, pp. 75-84

2006

  1. Erratum: Rituximab in the management of chronic immune thrombocytopenic purpura: An effective and safe therapeutic alternative in refractory patients (Annals Hematology (2006) 10.1007/s00277-005-0073-1)

    Annals of Hematology

  2. Rituximab in the management of chronic immune thrombocytopenic purpura: An effective and safe therapeutic alternative in refractory patients

    Annals of Hematology, Vol. 85, Núm. 6, pp. 400-406

2003

  1. Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: Influence of dose and stem cell source shows better outcome with rich marrow

    Blood, Vol. 102, Núm. 8, pp. 3043-3051